Good service means doing it right the first time, on time.
PBL senior managers are highly qualified, knowledgeable, experienced, and focused.
We are on our way to becoming a paperless laboratory with optimal workflows with the implementation of STARLIMS in 2023.
Our facility is purpose built with cGMP and GLP compliance in mind.
Martin Spalding, Sr. started PBL to provide an unmet need in the science community.
Small and Large Molecule Manufacturing Support.
Small and Large Molecule Development Support.
Immunogenicity and Bioanalysis for Clinical Trials.
Medical Device, Delivery Device, and Combination Product Services.
Access your reports, study and submission status, invoices, quotes and purchase order information all at one secure location on the web.
Pacific BioLabs once again received approval for continuance of ISO 17025:2017 accreditation, General Requirements for the Competence of Testing and Calibration Laboratories, as a result of a surveillance audit by ANSI National Accreditation Board (ANAB). The scope for PBL’s 17025 accreditation includes: Biocompatibility Testing Chemical Characterization by ISO 10993-18 Bioassays Cleaning and Disinfection Validation Cytotoxicity Testing […]
Pacific BioLabs (PBL) is pleased to announce the launch of In Vitro Services offering in vitro, cell-based assays supporting the pharmaceutical, biopharma, and medical device industries. The addition of this group to the PBL testing portfolio increases upon and is complimentary to well-established testing capabilities in our Microbiology, Analytical/Bioanalytical, and In Vivo departments. Cell-based assays […]
At Pacific BioLabs we have the vision of a paper-free laboratory. With the help of the state-of-the-art LIMS technology of STARLIMS, we are in the process of making this vision a reality. By implementing STARLIMS integrated solutions, we are optimizing regulatory compliance while increasing laboratory efficiency. In-lab workflows will be streamlined and transcription errors minimized […]
